RxDoctor Payments Data

Brittany Luke

Family · Winder, GANPI 1871011890

Payments from drug & device makers

$4,916in general payments, 2019–2025

Across 236 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$617
  • Bayer$598
  • Lilly USA, LLC$576
  • AstraZeneca$505
  • Esperion Therapeutics, Inc.$483
  • Abbott$418
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,84399%
  • Education$731%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,916 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide58$69,982
FarxigaDapagliflozin Propanediol38$35,029
JardianceEmpagliflozin22$29,881
EliquisApixaban23$23,732
NexlizetBempedoic Acid/Ezetimibe11$4,411
Ezetimibe150$3,304
Rosuvastatin Calcium171$2,644
Levothyroxine Sodium138$2,059
Atorvastatin Calcium106$1,382
Losartan Potassium77$1,193
Amlodipine Besylate116$802
Metformin Hcl ErMetformin Hcl52$748
Fluticasone Propionate49$745
Mirtazapine18$692
Omeprazole44$658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$576$69,98258 claims
AstraZenecaFarxiga$505$35,02938 claims
Boehringer IngelheimJardiance$85$29,88122 claims
PfizerEliquis$68$23,73223 claims
Esperion Therapeutics, Inc.Nexlizet$483$4,41111 claims
AbbVieSynthroid$137$62214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Winder

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →